Manufacturers Life Insurance Company, The Argenx Se Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Argenx Se stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 62,113 shares of ARGX stock, worth $40 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
62,113
Previous 61,586
0.86%
Holding current value
$40 Million
Previous $33.4 Million
14.37%
% of portfolio
0.04%
Previous 0.03%
Shares
18 transactions
Others Institutions Holding ARGX
# of Institutions
432Shares Held
29.2MCall Options Held
390KPut Options Held
272K-
Price T Rowe Associates Inc Baltimore, MD5.52MShares$3.56 Billion0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.07MShares$1.98 Billion3.02% of portfolio
-
Janus Henderson Group PLC London, X02.31MShares$1.49 Billion0.76% of portfolio
-
Capital World Investors Los Angeles, CA1.79MShares$1.15 Billion0.17% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$798 Million11.1% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $35.7B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...